8. ハンチントン病
[臨床試験数:197,薬物数:171(DrugBank:54),標的遺伝子数:82,標的パスウェイ数:144

Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02101957
(ClinicalTrials.gov)
October 201025/3/2014Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)Huntington's DiseaseDrug: RP103;Drug: PlaceboUniversity Hospital, AngersNULLActive, not recruiting18 Years65 YearsBoth96Phase 2;Phase 3France
2EUCTR2010-019444-39-FR
(EUCTR)
18/06/201004/05/2010Essai multicentrique de traitement de la maladie de Huntington par la cystéamine - CYST-HDEssai multicentrique de traitement de la maladie de Huntington par la cystéamine - CYST-HD Maladie de Huntington.
MedDRA version: 12.1;Level: LLT;Classification code 10020469;Term: Huntington's chorea
Product Name: Cysteamine Bitartrate
Product Code: RP 103
Centre Hospitalier Universitaire d'AngersNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
France